首页> 外文期刊>Journal of Advanced Pharmaceutical Technology Research >Design, synthesis, and antimicrobial screening of novel pyridyl-2-amidrazone incorporated isatin mannich bases
【24h】

Design, synthesis, and antimicrobial screening of novel pyridyl-2-amidrazone incorporated isatin mannich bases

机译:设计,合成和抗菌筛选新型吡啶-2-氨基dra酮结合的靛红甘露醇碱。

获取原文
       

摘要

Isatin is an endogenous compound and reported to possess a wide range of biological activities. Numerous papers have shown that the pyridyl-2-amidrazone nucleus possesses a potent antimicrobial activity. Based on these prior observations, we postulated that a compound containing both isatin and pyridyl-2-amidrazone pharmacophores could be very effective for antimicrobial activity. Unfavorable adsorption, distribution, metabolism, and excretion (ADME) properties can in manycases lead to the clinical trials failure of potentially successful drug candidates. Their evaluation, therefore, at an earlier stage is desired. Here, we also present the predicted ADME properties of our ligands through computation. All the compounds (2a1–5) exhibited a better solubility, diffusion, Log P, molecular weight, etc., with no violations making the ligands pharmacodynamically active and better oral absorptive series. Based on the results of computational design, a series of novel pyridyl-2-amidrazone-incorporated isatin Mannich bases were synthesized and screened for their antimicrobial activities. IR, 1H-NMR, and Mass Spectroscopy data were consistent with the assigned structures. The results exhibited that all of the lead compounds showed good antimicrobial activities; noticeably, the compound 2a2 showed the best activity against Candida albicans (16 μg/ml) and compound 2a3 was found to be the most active derivative against Staphylococcus aureus and Escherichia coli at minimal inhibitory concentration values of 4 and 32 μg/ml, respectively.Keywords: Antimicrobial activity, isatin, Lipinski's rule of 5, pyridyl-2-amidrazone
机译:Isatin是一种内源性化合物,据报道具有广泛的生物活性。许多论文表明,吡啶基-2-氨基dra核具有强大的抗菌活性。基于这些先前的观察,我们推测同时包含伊斯汀和吡啶基-2-氨基dra酮药效基团的化合物可能对抗菌活性非常有效。在许多情况下,不利的吸附,分布,代谢和排泄(ADME)特性可能导致潜在成功候选药物的临床试验失败。因此,需要在早期对其进行评估。在这里,我们还通过计算介绍了配体的预测ADME特性。所有化合物(2a1-5)均表现出更好的溶解性,扩散性,Log P,分子量等,并且没有违反规定,使配体具有药理活性,并具有更好的口服吸收系列。基于计算设计的结果,合成了一系列新的掺有吡啶基-2-ami啶酮的靛红曼尼希碱,并筛选了它们的抗菌活性。 IR,1 H-NMR和质谱数据与指定的结构一致。结果表明,所有先导化合物均具有良好的抗菌活性。值得注意的是,在最小抑菌浓度分别为4和32μg/ ml的情况下,化合物2a2对白色念珠菌具有最佳活性(16μg/ ml),化合物2a3对金黄色葡萄球菌和大肠杆菌的活性最高。关键字:抗菌活性,伊斯汀,李平斯基5规则,吡啶-2-氨基ami

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号